Fosaprepitant

Fosaprepitant
Klinički podaci
Podaci o licenci
Kategorija trudnoće
  • US: B (Bez rizika u ispitivanjima na životinjama)
Način primeneIntravenozno
Pravni status
Pravni status
Identifikatori
CAS broj172673-20-0 Зелена квачицаДа
265121-04-8 (dimeglumin)
ATC kodA04AD12 (WHO)
PubChemCID 219090

Fosaprepitant (Emend injekcije (SAD), Ivemend (EU)) je antiemetički lek, koji se upotrebljava intravenozno. On je prolek aprepitanta.

Fosaprepitant je razvio Merk. On je odobren u SAD FDA 25. januara, 2008.[1] i EMA 11. januara iste godine.[2]

Vidi još

Reference

Spoljašnje veze

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.